Researchers have developed a new compound, ZTA-261, that binds to thyroid hormone receptor beta (THR ). THR plays an important role in the regulation of lipid metabolism, which affects lipid levels in ...
In recent years, mRNA in lipid nanoparticles (mRNA–LNPs) has emerged as a promising strategy for treating numerous conditions ...
This statement summarizes the current U.S. Preventive Services Task Force (USPSTF) recommendation on screening for lipid disorders in children. This recommendation statement was first published in ...
Hosted on MSN
First-in-human trial of CRISPR gene-editing therapy safely lowers cholesterol and triglycerides
In a 15-patient, Phase 1, first-in-human trial, a one-time CRISPR-Cas9 gene-editing therapy safely reduced LDL cholesterol and triglycerides in people with difficult-to-treat lipid disorders, ...
A team of medics performing CPR and inserting an IV drip on a patient lying unconscious in a hospital bed. [iStockphoto] When 19-year-old *Jeffrey walked into Aga Khan Hospital after suffering a heart ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The intended audience for this activity is cardiologists ...
Elevated lipoprotein(a) levels can slowly block the arteries, increasing the likelihood of cardiovascular disease. Since no treatment is currently available for this condition, it is essential to ...
A recent study by the University of Bonn and University Hospital Bonn and the University of Freiburg shows that the ...
Scientists at Nagoya University in Japan have made a significant breakthrough in treating lipid disorders. They have developed a new compound, ZTA-261, which selectively binds to the thyroid hormone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results